Fibrosarcoma or Lewis lung carcinoma (LLC) cells modified to constitutively secrete IL-1β were shown in vivo to promote angiogenesis, through the induction of VEGF, CXCL2, and hepatocyte growth factor production by cancer and stromal cells, leading to tumor progression [68,187,188]. This evidence concerns the gene IL1B and neoplasm.